Cargando…
Successful resolution of hemophagocytic lymphohistiocytosis during the chemotherapy course of acute myelocytic leukemia with ruxolitinib
Autores principales: | Song, Yue, Wang, Jingshi, Wang, Xinkai, Wang, Yini, Wang, Zhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769109/ https://www.ncbi.nlm.nih.gov/pubmed/34054023 http://dx.doi.org/10.1097/CM9.0000000000001559 |
Ejemplares similares
-
Dose-escalating ruxolitinib for refractory hemophagocytic lymphohistiocytosis
por: Song, Yue, et al.
Publicado: (2023) -
Acute myelocytic leukemia in a patient with hemophagocytic lymphohistiocytosis: A case report
por: ZHAO, DEFENG, et al.
Publicado: (2014) -
Ruxolitinib treatment for bronchiolitis obliterans syndrome following hematopoietic stem cell transplant in a patient with primary hemophagocytic lymphohistiocytosis
por: Meng, Guang-Qiang, et al.
Publicado: (2021) -
The Treatment Based on Ruxolitinib and Amphotericin B is Effective for Relapsed Leishmaniasis-Related Hemophagocytic Lymphohistiocytosis: A Case Report and Literature Review
por: Cui, Tingting, et al.
Publicado: (2022) -
HLA-mismatched GPBSC infusion therapy in refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: an observational study from a single center
por: Song, Yue, et al.
Publicado: (2020)